v3.25.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees

The following table summarizes the stock-based compensation expense for stock options granted to employees and non-employees:

 

 

 

Three months ended March 31,

 

 

 

2025

 

 

2024

 

Research and development

 

$

453,186

 

*

$

17,931

 

Selling, general and administrative

 

 

1,589,010

 

 

 

35,503

 

Total stock-based compensation expense

 

$

2,042,196

 

 

$

53,434

 

*Includes $0.3 million related to the restricted stock awards issued in connection with the acquisition of CorHepta.